Mark Z.
- Country
- Sweden
- Department
- Head, Neck, Lung and Skin cancer
Research Overview
- Evaluation of [Main Substance] in Combination with Other Agents for Patients with Metastatic Clear Cell or Papillary Renal Cell Carcinoma and End-Stage Renal Disease
- Efficacy and Safety of Bupivacaine Hydrochloride Monohydrate versus Lidocaine Hydrochloride for the Management of Oral Mucositis-Associated Pain in Head and Neck Cancer Patients
Data & Insights
Has run more than one trial at 1 of 13 partner sites.
Specializations
Head and Neck Oncology
Clinical research activity in head and neck cancer and related upper aerodigestive tract malignancies, with interest in treatment strategies for locally advanced, recurrent, and metastatic disease.
- Head and neck squamous cell carcinoma
- Oral squamous cell carcinoma
- Esophageal squamous cell carcinoma
- Cervical cancer
Research involvement also extends to immunotherapy and targeted therapy approaches in advanced solid tumors affecting the head, neck, and adjacent gastrointestinal regions.
Lung Cancer and Thoracic Malignancies
Active in non-small cell lung cancer, small-cell lung cancer, and other thoracic cancers, with a focus on disease control in advanced and molecularly defined settings.
- Non-small cell lung cancer
- Small-cell lung cancer
- Malignant pleural mesothelioma
- Pulmonary fibrosis
Therapeutic interests include checkpoint inhibition, precision oncology, and treatment options for EGFR- and KRAS-altered tumors.
Melanoma and Skin Cancer
Research spans cutaneous melanoma, advanced melanoma, and other skin cancers, including high-risk and metastatic disease.
- Cutaneous malignant melanoma
- Advanced melanoma
- High-risk resected melanoma
- Prurigo nodularis
Clinical interests include adjuvant immunotherapy, immune-based treatment, and biomarker-informed management of melanoma and related dermatologic malignancies.
Hematologic Malignancies
Involvement in lymphoid and myeloid neoplasms covers both relapsed and treatment-naive disease, with emphasis on difficult-to-treat blood cancers.
- Diffuse large B-cell lymphoma
- Chronic lymphocytic leukemia
- Acute myeloid leukemia
- Multiple myeloma
Therapeutic focus includes B-cell directed therapy, cellular therapy, and novel approaches for lymphoma and plasma cell disorders.
Solid Tumors and Precision Therapeutics
Research activity also covers a broad range of advanced solid tumors, including breast cancer, prostate cancer, ovarian cancer, renal cell carcinoma, and urothelial carcinoma.
- Breast cancer
- Prostate cancer
- Renal cell carcinoma
- Urothelial carcinoma
Interest is centered on targeted agents, combination immunotherapy, and treatment innovation for molecularly selected advanced cancers.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.